Relevance of donor source to T-cell regeneration after bone marrow transplantation for severe combined immunodeficiency.
Airò
P
P
Brugnoni
D
D
Malagoli
A
A
Pennacchio
M
M
Porta
F
F
Cattaneo
R
R
D016026:Bone Marrow Transplantation / Q000276:immunology / Q000401:mortality / Q000473:pathology*; D002648:Child; D006085:Graft Survival; D006680:HLA Antigens / Q000032:analysis / Q000276:immunology; D006648:Histocompatibility; D006801:Humans; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation / Q000187:drug effects; D010835:Phytohemagglutinins / Q000494:pharmacology; D016511:Severe Combined Immunodeficiency / Q000628:therapy*; D016019:Survival Analysis; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology*; D014019:Tissue Donors
D006680:HLA Antigens; D010835:Phytohemagglutinins